![Paul Quadros](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Paul Quadros
Direktor/Vorstandsmitglied bei
Virrx, Inc.
Profil
Mr. Paul D.
Quadros is Lead Independent Director at Multivir, Inc. and a Principal at Band of Angels LLC.
He is on the Board of Directors at Multivir, Inc., Virrx, Inc. and White Electronic Designs Corp.
Mr. Quadros was previously employed as Chairman by Corautus Genetics, Inc., Chairman by Cardiac Science Corp., General Partner by Technology Funding, Inc., Managing Partner by Tenex Greenhouse Ventures LLC, General Partner by Tenex Medical, Inc., and Chief Executive Officer by Theregen, Inc. He also served on the board at Artielle ImmunoTherapeutics, Inc., NovoStent Corp.
and Vandolay, Inc.
He received his undergraduate degree from California State University-Fullerton and an MBA from UCLA Anderson School of Management.
Aktive Positionen von Paul Quadros
| Unternehmen | Position | Beginn |
|---|---|---|
Virrx, Inc. | Direktor/Vorstandsmitglied | 01.03.2013 |
Visura Technologies Inc
 Visura Technologies Inc Information Technology ServicesTechnology Services Provides information technology services | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Paul Quadros
| Unternehmen | Position | Ende |
|---|---|---|
Tenex Greenhouse Ventures LLC
 Tenex Greenhouse Ventures LLC Investment ManagersFinance Tenex Greenhouse Ventures invests in US-based life sciences companies operating in the fields of biotechnology, health and medical devices. The firm acts as a lead investor and provides financing for seed, startups, spin-out and re-start transactions with an investment size of $1 - $1.25 million. It makes follow on investments and also considers co-investments. | Private Equity Investor | 01.12.2012 |
Corautus Genetics, Inc.
 Corautus Genetics, Inc. Pharmaceuticals: MajorHealth Technology Develops gene therapy pharmaceutical products | Vorsitzender | 07.06.2007 |
Cardiac Science Corp.
 Cardiac Science Corp. Medical SpecialtiesHealth Technology Develops, manufactures, and markets cardiovascular equipment | Vorsitzender | 01.01.2003 |
Technology Funding, Inc.
 Technology Funding, Inc. Investment ManagersFinance Technology Funding participates in early stage capital transactions and focuses on sectors such as medical devices, diagnostics, biotechnology, medical information systems and healthcare services. | Corporate Officer/Principal | 01.01.1995 |
Multivir, Inc.
 Multivir, Inc. BiotechnologyHealth Technology Develops novel tumor suppressor and immune gene therapies | Direktor/Vorstandsmitglied | - |
Ausbildung von Paul Quadros
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
37
Beziehungen ersten Grades
15
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 15 |
|---|---|
Corautus Genetics, Inc.
Corautus Genetics, Inc. Pharmaceuticals: MajorHealth Technology Develops gene therapy pharmaceutical products | Health Technology |
Technology Funding, Inc.
Technology Funding, Inc. Investment ManagersFinance Technology Funding participates in early stage capital transactions and focuses on sectors such as medical devices, diagnostics, biotechnology, medical information systems and healthcare services. | Finance |
Microsemi Corp. - Memory & Storage Solutions
 Microsemi Corp. - Memory & Storage Solutions SemiconductorsElectronic Technology Manufactures and supplies electronics components for defense and aerospace markets | Electronic Technology |
NovoStent Corp.
 NovoStent Corp. Commercial Printing/FormsCommercial Services Develops and manufactures helical stent and delivery systems | Commercial Services |
Artielle ImmunoTherapeutics, Inc.
 Artielle ImmunoTherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs to treat a range of inflammatory and degenerative diseases | Health Technology |
Theregen, Inc.
 Theregen, Inc. Miscellaneous Commercial ServicesCommercial Services Develops cell based therapies for cardiovascular and vascular disorders | Commercial Services |
Vandolay, Inc.
 Vandolay, Inc. Financial ConglomeratesFinance Operates as a blank check company | Finance |
California State University-Fullerton
 California State University-Fullerton Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tenex Greenhouse Ventures LLC
Tenex Greenhouse Ventures LLC Investment ManagersFinance Tenex Greenhouse Ventures invests in US-based life sciences companies operating in the fields of biotechnology, health and medical devices. The firm acts as a lead investor and provides financing for seed, startups, spin-out and re-start transactions with an investment size of $1 - $1.25 million. It makes follow on investments and also considers co-investments. | Finance |
Cardiac Science Corp.
Cardiac Science Corp. Medical SpecialtiesHealth Technology Develops, manufactures, and markets cardiovascular equipment | Health Technology |
Tenex Medical, Inc.
 Tenex Medical, Inc. Investment ManagersFinance Tenex Medical makes early-stage investments in several healthcare-related sectors including medical devices, healthcare information systems and services, clinical diagnostics, research products, information systems, medical equipment, hospital products and biotechnology. They generally invest $250,000 to $750,000 which may constitute all or part of a financing round | Finance |
UCLA Anderson School of Management
 UCLA Anderson School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Multivir, Inc.
Multivir, Inc. BiotechnologyHealth Technology Develops novel tumor suppressor and immune gene therapies | Health Technology |
Virrx, Inc. | |
Visura Technologies Inc
Visura Technologies Inc Information Technology ServicesTechnology Services Provides information technology services | Technology Services |
